OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research roundup

Debbie Rigby 03/05/2016

Debbie Rigby presents the latest research news relevant to pharmacy Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus Previous trial results have suggested that DPP4 inhibitors might increase heart failure (HF) risk in patients with type 2 diabetes mellitus (T2DM). Secondary Analysis of the TECOS randomised controlled

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Research roundup

Previous Pharmacists key in cardiac rehabilitation

Next Forum: What’s the go with the 1 July NDSS changes?

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Pharmacists key in cardiac rehabilitation

Next Forum: What’s the go with the 1 July NDSS changes?

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.